Inmar's ESG Commitment

Understanding ESG and Sustainability at Inmar

At Inmar, we believe smarter business means protecting the planet, creating value for people, and delivering results that last. That’s why we’ve launched a strategic ESG (Environmental, Social, and Governance) program that’s laying the groundwork for long-term impact. From reducing waste to reinforcing ethics in healthcare compliance, ESG is embedded in our everyday actions — and it’s helping us deliver smarter, more resilient solutions to our customers and communities.
Groceryshop 2025

Groceryshop 2025

At Groceryshop 2025, Inmar invites you to bring us your toughest challenge. Whether you're navigating tighter budgets, fragmented retail media, or a loyalty landscape that’s shifting beneath your feet—we’re ready to listen, learn, and provide solutions.

Inmar Intelligence Names Srini Varadarajan Chief Technology Officer

Inmar Intelligence, a leading data-driven technology company, today announced the appointment of Srini Varadarajan as Chief Technology Officer (CTO), underscoring its strategic commitment to advancing innovation and accelerating growth through industry-leading technology. The appointment of Srini as CTO reflects Inmar's ongoing commitment to delivering unparalleled value to its customers, partners, and stakeholders.
Ascendant Content Mandate Report Header

The New Content Mandate Report Published by Ascendant Network

The New Content Mandate: Building Shopper Trust in a Fragmented Retail Media Landscape In the New Content Mandate: Building Shopper Trust in a Fragmented Retail Media Landscape report conducted by Ascendant Network in partnership with Inmar Intelligence, we learned how the retail media industry is evolving from banner ads and siloed promotional campaigns to meaningful, omnichannel content experiences to build strong consumer connections.  
A Modern Safeguard for Product Authenticity and Safety

Beyond Compliance: How Decommissioning Serial Numbers Strengthens the Pharma Supply Chain

Decommissioning serial numbers is emerging as a critical best practice in the pharmaceutical industry, enhancing DSCSA compliance and supply chain integrity. By formally retiring products from the supply chain using standardized EPCIS data, manufacturers can prevent fraud, support audits, and improve traceability. This proactive step strengthens patient safety and protects against the re-entry of counterfeit or expired drugs.